Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 13 studies | 29% ± 9% | |
fibroblast | 12 studies | 24% ± 6% | |
oligodendrocyte | 11 studies | 30% ± 10% | |
mesothelial cell | 9 studies | 49% ± 22% | |
adipocyte | 9 studies | 40% ± 12% | |
myofibroblast cell | 7 studies | 33% ± 15% | |
epithelial cell | 7 studies | 35% ± 10% | |
basal cell | 6 studies | 26% ± 9% | |
glutamatergic neuron | 6 studies | 26% ± 9% | |
ionocyte | 5 studies | 60% ± 9% | |
smooth muscle cell | 5 studies | 32% ± 18% | |
adventitial cell | 5 studies | 27% ± 3% | |
abnormal cell | 4 studies | 21% ± 2% | |
endothelial cell | 4 studies | 25% ± 12% | |
retinal pigment epithelial cell | 4 studies | 38% ± 12% | |
cardiac muscle cell | 4 studies | 29% ± 3% | |
Schwann cell | 4 studies | 49% ± 20% | |
neuron | 4 studies | 29% ± 8% | |
melanocyte | 4 studies | 41% ± 18% | |
myoepithelial cell | 4 studies | 45% ± 14% | |
renal alpha-intercalated cell | 4 studies | 44% ± 13% | |
secretory cell | 3 studies | 19% ± 4% | |
connective tissue cell | 3 studies | 22% ± 7% | |
club cell | 3 studies | 25% ± 4% | |
glial cell | 3 studies | 32% ± 12% | |
respiratory goblet cell | 3 studies | 18% ± 1% | |
alveolar macrophage | 3 studies | 43% ± 7% | |
GABAergic neuron | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 4892.91 | 245 / 245 | 96% | 74.31 | 482 / 502 |
bladder | 100% | 4945.33 | 21 / 21 | 93% | 59.91 | 468 / 504 |
breast | 97% | 3800.70 | 443 / 459 | 93% | 104.44 | 1041 / 1118 |
intestine | 98% | 6702.15 | 942 / 966 | 88% | 41.58 | 462 / 527 |
lung | 99% | 3185.22 | 574 / 578 | 85% | 42.72 | 984 / 1155 |
stomach | 95% | 2879.41 | 342 / 359 | 84% | 38.88 | 239 / 286 |
uterus | 96% | 4384.41 | 164 / 170 | 81% | 44.95 | 374 / 459 |
skin | 97% | 4231.04 | 1763 / 1809 | 78% | 52.29 | 368 / 472 |
ovary | 95% | 5031.35 | 171 / 180 | 74% | 21.56 | 319 / 430 |
esophagus | 79% | 3862.57 | 1136 / 1445 | 89% | 60.82 | 163 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 52.49 | 1 / 1 |
adipose | 99% | 5412.00 | 1187 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 3050.43 | 1306 / 1335 | 0% | 0 | 0 / 0 |
kidney | 52% | 759.04 | 46 / 89 | 45% | 23.43 | 406 / 901 |
pancreas | 1% | 10.53 | 3 / 328 | 89% | 55.03 | 159 / 178 |
heart | 87% | 2128.35 | 746 / 861 | 0% | 0 | 0 / 0 |
muscle | 62% | 1060.21 | 494 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 56% | 22.61 | 25 / 45 |
spleen | 53% | 938.22 | 127 / 241 | 0% | 0 | 0 / 0 |
brain | 29% | 412.95 | 761 / 2642 | 23% | 5.60 | 162 / 705 |
adrenal gland | 27% | 281.37 | 70 / 258 | 12% | 3.07 | 27 / 230 |
thymus | 21% | 264.85 | 137 / 653 | 10% | 1.93 | 63 / 605 |
eye | 0% | 0 | 0 / 0 | 16% | 7.20 | 13 / 80 |
liver | 0% | 5.88 | 1 / 226 | 6% | 1.88 | 25 / 406 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.44 | 1 / 29 |
peripheral blood | 0% | 1.84 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001974 | Biological process | blood vessel remodeling |
GO_0003148 | Biological process | outflow tract septum morphogenesis |
GO_0009791 | Biological process | post-embryonic development |
GO_0001755 | Biological process | neural crest cell migration |
GO_0140074 | Biological process | cardiac endothelial to mesenchymal transition |
GO_0060174 | Biological process | limb bud formation |
GO_0060666 | Biological process | dichotomous subdivision of terminal units involved in salivary gland branching |
GO_0050919 | Biological process | negative chemotaxis |
GO_0006955 | Biological process | immune response |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_1905312 | Biological process | positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO_0001756 | Biological process | somitogenesis |
GO_0003350 | Biological process | pulmonary myocardium development |
GO_0071526 | Biological process | semaphorin-plexin signaling pathway |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0021915 | Biological process | neural tube development |
GO_0007411 | Biological process | axon guidance |
GO_0003215 | Biological process | cardiac right ventricle morphogenesis |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0030215 | Molecular function | semaphorin receptor binding |
GO_0045499 | Molecular function | chemorepellent activity |
Gene name | SEMA3C |
Protein name | Semaphorin-3C (Semaphorin-E) (Sema E) Semaphorin 3C Uncharacterized protein SEMA3C |
Synonyms | SEMAE |
Description | FUNCTION: Binds to plexin family members and plays an important role in the regulation of developmental processes. Required for normal cardiovascular development during embryogenesis. Functions as attractant for growing axons, and thereby plays an important role in axon growth and axon guidance (By similarity). . |
Accessions | Q75MX0 Q75L25 ENST00000265361.8 [Q99985-1] ENST00000458729.5 ENST00000411788.5 ENST00000427167.5 Q99985 ENST00000419255.6 [Q99985-1] F2Z2Y0 F8WEP9 |